Skip to main content
OpenTrials

Clinical trial condition

Rectal Diseases

Explore clinical trials studying Rectal Diseases. Study availability and eligibility vary by location and protocol.

5,978 public trials 1,259 recruiting studies
Refine in advanced search Browse all conditions

Rectal Diseases trial results

Completed

A Phase I Trial of LY3143921 Hydrate in Solid Tumours

NCT03096054

Conditions
Breast Cancer (Triple Negative Type), Breast Diseases, Breast Neoplasms, +44 more
Locations
  • Northern Ireland Cancer Centre Belfast, United Kingdom
  • Western General Hospital Edinburgh, United Kingdom
  • Beatson West of Scotland Cancer Centre Glasgow, United Kingdom
  • Northern Centre for Cancer Care Newcastle upon Tyne, United Kingdom
View Trial Details
Completed

Encorafenib, Binimetinib and Cetuximab in Subjects With Previously Untreated BRAF-mutant ColoRectal Cancer

NCT03693170

Conditions
BRAF V600E-mutant Metastatic Colorectal Cancer, Colonic Diseases, Colorectal Neoplasms, +9 more
Locations
  • Memorial Sloan Kettering Cancer Center New York, United States
  • PC dba West Cancer Center Germantown, Tennessee, United States
  • Krankenhaus der Barmherzigen Brüder Vienna, Austria
  • UZ Gent, Gastro-Enterology Ghent, East Flanders, Belgium
View all 45 locations
View Trial Details
Completed

A Phase 1 Study of Pegilodecakin (LY3500518) in Participants With Advanced Solid Tumors

NCT02009449

Conditions
Adenocarcinoma, Adnexal Diseases, Breast Cancer, +64 more
Locations
  • UCLA Medical Hematology & Oncology Los Angeles, California, United States
  • UCSF San Francisco, California, United States
  • Sarah Cannon Research Institute at HealthONE Denver, Colorado, United States
  • Florida Cancer Specialists & Research Institute Sarasota, Florida, United States
View Trial Details

Related conditions